Therapeutic approaches for COVID-19: Myths and facts (AAC ed.)

<p>Objectives:<br /> • Discuss the therapeutic options currently being used for COVID-19<br /> • Evaluate some clinical data supporting the use of these drugs<br /> • Comment on clinical trials and enrollment</p> <p>Participants:<br /> • Andre Kalil, Professor, University of Nebraska Medical Center, Omaha, NB, USA. Lead Investigator, NIH Clinical Trial for COVId-19<br /> • Miguel A. Martinez, Editor AAC. Professor, AIDS Research Institute-IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.</p> <p>Visit https://aac.asm.org/ to browse issues and/or submit a manuscript.</p>